Varex Imaging (NASDAQ:VREX – Get Free Report) had its target price lowered by equities researchers at Oppenheimer from $30.00 to $23.00 in a research report issued on Friday,Benzinga reports. The brokerage presently has an “outperform” rating on the stock. Oppenheimer’s price target indicates a potential upside of 90.37% from the company’s current price.
A number of other research analysts have also weighed in on VREX. B. Riley reissued a “buy” rating and set a $22.00 price target (up from $21.00) on shares of Varex Imaging in a research report on Friday. StockNews.com cut shares of Varex Imaging from a “buy” rating to a “hold” rating in a research note on Thursday, January 30th.
Check Out Our Latest Stock Report on VREX
Varex Imaging Trading Down 20.5 %
Varex Imaging (NASDAQ:VREX – Get Free Report) last posted its quarterly earnings data on Thursday, February 6th. The company reported $0.07 earnings per share for the quarter, topping the consensus estimate of $0.04 by $0.03. Varex Imaging had a negative net margin of 5.88% and a positive return on equity of 3.85%. As a group, analysts predict that Varex Imaging will post 0.63 earnings per share for the current fiscal year.
Hedge Funds Weigh In On Varex Imaging
A number of institutional investors have recently made changes to their positions in VREX. Squarepoint Ops LLC increased its holdings in shares of Varex Imaging by 132.1% in the 2nd quarter. Squarepoint Ops LLC now owns 26,380 shares of the company’s stock worth $389,000 after buying an additional 15,014 shares during the last quarter. CWM LLC boosted its position in Varex Imaging by 2,384.2% during the 3rd quarter. CWM LLC now owns 9,589 shares of the company’s stock valued at $114,000 after buying an additional 9,203 shares during the period. Wedge Capital Management L L P NC lifted its position in shares of Varex Imaging by 32.3% in the 3rd quarter. Wedge Capital Management L L P NC now owns 107,900 shares of the company’s stock worth $1,286,000 after purchasing an additional 26,321 shares during the period. Creative Planning lifted its position in shares of Varex Imaging by 9.2% in the 3rd quarter. Creative Planning now owns 19,644 shares of the company’s stock worth $234,000 after purchasing an additional 1,654 shares during the period. Finally, Inspire Advisors LLC lifted its position in Varex Imaging by 29.8% during the 3rd quarter. Inspire Advisors LLC now owns 14,149 shares of the company’s stock valued at $169,000 after acquiring an additional 3,245 shares during the period.
Varex Imaging Company Profile
Varex Imaging Corporation designs, manufactures, and sells X-ray imaging components. The company operates through two segments, Medical and Industrial. The Medical segment designs, manufactures, sells, and services X-ray imaging components, comprising X-ray tubes, digital detectors and accessories, ionization chambers, high voltage connectors, image-processing software and workstations, 3D reconstruction software, computer-aided diagnostic software, collimators, automatic exposure control devices, generators, and heat exchangers.
See Also
- Five stocks we like better than Varex Imaging
- Health Care Stocks Explained: Why You Might Want to Invest
- IBM’s AI Bet Pays Off—What’s Next for Investors?
- What is a buyback in stocks? A comprehensive guide for investors
- 3 Reasons to Treat AMD’s Drop as an Entry Opportunity
- Diversification Can Smooth Returns And Mitigate Portfolio Risk
- Qualcomm’s Post-Earnings Dip: A Prime Buying Opportunity?
Receive News & Ratings for Varex Imaging Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Varex Imaging and related companies with MarketBeat.com's FREE daily email newsletter.